Clinical Trials Browser

Phase 2 × Nasopharyngeal Neoplasms × Gentamicins × Clear all

NCT02735317 2016-04-12

Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Phase 2 Unknown

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Stomatitis